As of June 30, 2026, Orexo AB carries a market capitalization of 74.74M, placing it among publicly traded companies globally. Its enterprise value stands at 47.20M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 74.74M |
| Enterprise Value | 47.20M |
Orexo AB's next confirmed earnings release is scheduled for October 22, 2026.
| Earnings Date | 10/22/2026 |
As of June 30, 2026, Orexo AB has 35.13M shares outstanding.
| Shares Outstanding | 35.13M |
These figures are as of June 30, 2026.
| PB Ratio | 2.67 |
| P/TBV Ratio | 2.68 |
As of June 30, 2026, Orexo AB maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.65 |
| Quick Ratio | 1.20 |
| Debt / Equity | 3.65 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 83.00 |
Over the twelve months ended June 30, 2026, Orexo AB recorded 134,088.08 in income tax expense.
| Income Tax | 134,088.08 |
As of the close on October 22, 2026, Orexo AB's stock has declined approximately 81.05% over the past 52 weeks.
| 52-Week Price Change | -81.05% |
As of June 30, 2026, Orexo AB holds 28.56M in cash and equivalents against 1.02M in total debt, resulting in a net debt position of -28.56M. Total book value stands at 27.98M, with working capital of 15.46M providing operational flexibility.
| Cash & Cash Equivalents | 28.56M |
| Total Debt | 1.02M |
| Net Debt | -28.56M |
| Equity (Book Value) | 27.98M |
| Book Value Per Share | 0.80 |
| Working Capital | 15.46M |
These figures cover the twelve months ended June 30, 2026.
| Capital Expenditures | -185,660.41 |
Already premium?